News

As a result, a market for cheaper, off-brand versions of their active ingredients — semaglutide and tirzepatide — has ...
All generate strong profit margins, which can help them weather a challenging economy. Many of the best growth stocks in the ...
Eli Lilly has morphed from a reliable pharma giant into a biotech powerhouse riding blockbuster success. Mounjaro and ...
As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...
Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand access soon.
Aimee Chapman, 34, from Southampton, was admitted to intensive care last summer after developing liver failure and a hole in ...
Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.
The collaboration will span over 200 Apollo clinics and involve 300 medical practitioners, focusing on patient education, ...
Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster ...
The US drugmaker has stolen a march on Novo Nordisk by bringing a viable oral weight-loss medicine, orforglipron, into successful phase 3 clinical trials. An oral version is the holy grail for drugs ...
FOR Hope Lancaster Colquhoun, her perfect smile had always been a source of pride – so it was a moment of pure horror when ...